A carregar...
Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice
Levosimendan is a calcium sensitizer and adenosine triphosphate–dependent potassium channel opener, which exerts sustained hemodynamic, symptomatic, and organ-protective effects. It is registered for the treatment of acute heart failure, and when inotropic support is considered appropriate. In the p...
Na minha lista:
| Publicado no: | J Cardiovasc Pharmacol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Journal of Cardiovascular Pharmacology
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5768218/ https://ncbi.nlm.nih.gov/pubmed/29076887 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0000000000000551 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|